140 related articles for article (PubMed ID: 8889697)
1. Identification of human glandular kallikrein hK2 from LNCaP cells.
Grauer LS; Charlesworth MC; Saedi MS; Finlay JA; Liu RS; Kuus-Reichel K; Young CY; Tindall DJ
J Androl; 1996; 17(4):353-9. PubMed ID: 8889697
[TBL] [Abstract][Full Text] [Related]
2. Expression of human glandular kallikrein, hK2, in mammalian cells.
Kumar A; Goel AS; Hill TM; Mikolajczyk SD; Millar LS; Kuus-Reichel K; Saedi MS
Cancer Res; 1996 Dec; 56(23):5397-402. PubMed ID: 8968092
[TBL] [Abstract][Full Text] [Related]
3. Expression of human prostate-specific glandular kallikrein protein (hK2) in the breast cancer cell line T47-D.
Hsieh ML; Charlesworth MC; Goodmanson M; Zhang S; Seay T; Klee GG; Tindall DJ; Young CY
Cancer Res; 1997 Jul; 57(13):2651-6. PubMed ID: 9205072
[TBL] [Abstract][Full Text] [Related]
4. Prostate-specific human kallikrein (hK2) as a novel marker for prostate cancer.
Young CY; Seay T; Hogen K; Charlesworth MC; Roche PC; Klee GG; Tindall DJ
Prostate Suppl; 1996; 7():17-24. PubMed ID: 8950360
[TBL] [Abstract][Full Text] [Related]
5. Detection of circulating prostate cells by reverse transcriptase-polymerase chain reaction of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) messages.
Corey E; Arfman EW; Oswin MM; Melchior SW; Tindall DJ; Young CY; Ellis WJ; Vessella RL
Urology; 1997 Aug; 50(2):184-8. PubMed ID: 9255285
[TBL] [Abstract][Full Text] [Related]
6. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.
Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Lümmen G; Wernli M; Wiefelspütz J; Graber SF; Goepel M; Huber A; Tscholl R
Cancer; 1998 Dec; 83(12):2540-7. PubMed ID: 9874461
[TBL] [Abstract][Full Text] [Related]
7. Detection of human glandular kallikrein, hK2, as its precursor form and in complex with protease inhibitors in prostate carcinoma serum.
Grauer LS; Finlay JA; Mikolajczyk SD; Pusateri KD; Wolfert RL
J Androl; 1998; 19(4):407-11. PubMed ID: 9733142
[TBL] [Abstract][Full Text] [Related]
8. Generation of monoclonal antibodies specific for human kallikrein 2 (hK2) using hK2-expressing tumors.
Fisher TL; Nocera M; Willis RA; Turner MJ; Abdul Alim CS; Brown DM; Bourne PA; di Sant'Agnese PA; Messing EM; Lord EM; Frelinger JG
Prostate; 2002 May; 51(3):153-65. PubMed ID: 11967950
[TBL] [Abstract][Full Text] [Related]
9. Measurement of prostate-specific antigen and human glandular kallikrein 2 in different body fluids.
Lövgren J; Valtonen-André C; Marsal K; Lilja H; Lundwall A
J Androl; 1999; 20(3):348-55. PubMed ID: 10386814
[TBL] [Abstract][Full Text] [Related]
10. Identification of the transcriptional regulatory sequences of human kallikrein 2 and their use in the construction of calydon virus 764, an attenuated replication competent adenovirus for prostate cancer therapy.
Yu DC; Sakamoto GT; Henderson DR
Cancer Res; 1999 Apr; 59(7):1498-504. PubMed ID: 10197620
[TBL] [Abstract][Full Text] [Related]
11. Structural comparison of prostate-specific antigen and human glandular kallikrein using molecular modeling.
Bridon DP; Dowell BL
Urology; 1995 May; 45(5):801-6. PubMed ID: 7538242
[TBL] [Abstract][Full Text] [Related]
12. Kininogenase activity of prostate-derived human glandular kallikrein (hK2) purified from seminal fluid.
Charlesworth MC; Young CY; Miller VM; Tindall DJ
J Androl; 1999; 20(2):220-9. PubMed ID: 10232657
[TBL] [Abstract][Full Text] [Related]
13. Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretions.
Black MH; Magklara A; Obiezu C; Levesque MA; Sutherland DJ; Tindall DJ; Young CY; Sauter ER; Diamandis EP
Br J Cancer; 2000 Jan; 82(2):361-7. PubMed ID: 10646889
[TBL] [Abstract][Full Text] [Related]
14. Detection of metastatic prostate cancer using a splice variant-specific reverse transcriptase-polymerase chain reaction assay for human glandular kallikrein.
Slawin KM; Shariat SF; Nguyen C; Leventis AK; Song W; Kattan MW; Young CY; Tindall DJ; Wheeler TM
Cancer Res; 2000 Dec; 60(24):7142-8. PubMed ID: 11156423
[TBL] [Abstract][Full Text] [Related]
15. Cross-reactivity of ten anti-prostate-specific antigen monoclonal antibodies with human glandular kallikrein.
Corey E; Buhler KR; Vessella RL
Urology; 1997 Oct; 50(4):567-71; discussion 571-2. PubMed ID: 9338733
[TBL] [Abstract][Full Text] [Related]
16. Different proportions of various prostate-specific antigen (PSA) and human kallikrein 2 (hK2) forms are present in noninduced and androgen-induced LNCaP cells.
Kumar A; Mikolajczyk SD; Hill TM; Millar LS; Saedi MS
Prostate; 2000 Aug; 44(3):248-54. PubMed ID: 10906742
[TBL] [Abstract][Full Text] [Related]
17. Large-scale propagation of recombinant adherent cells that secrete a stable form of human glandular kallikrein, hK2.
Kumar A; Goel AS; Payne JK; Evans C; Mikolajczyk SD; Kuus-Reichel K; Saedi MS
Protein Expr Purif; 1999 Feb; 15(1):62-8. PubMed ID: 10024471
[TBL] [Abstract][Full Text] [Related]
18. Development of an ultrasensitive immunoassay for human glandular kallikrein with no cross-reactivity from prostate-specific antigen.
Black MH; Magklara A; Obiezu CV; Melegos DN; Diamandis EP
Clin Chem; 1999 Jun; 45(6 Pt 1):790-9. PubMed ID: 10351987
[TBL] [Abstract][Full Text] [Related]
19. Human kallikrein 11: a new biomarker of prostate and ovarian carcinoma.
Diamandis EP; Okui A; Mitsui S; Luo LY; Soosaipillai A; Grass L; Nakamura T; Howarth DJ; Yamaguchi N
Cancer Res; 2002 Jan; 62(1):295-300. PubMed ID: 11782391
[TBL] [Abstract][Full Text] [Related]
20. Intact free prostate-specific antigen and free and total human glandular kallikrein 2. Elimination of assay interference by enzymatic digestion of antibodies to F(ab')2 fragments.
Väisänen V; Peltola MT; Lilja H; Nurmi M; Pettersson K
Anal Chem; 2006 Nov; 78(22):7809-15. PubMed ID: 17105175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
